145 related articles for article (PubMed ID: 2830866)
1. In vivo and in vitro interactions of TCDD and other ligands of the Ah-receptor: effect on embryonic and fetal tissues.
Hassoun EA
Arch Toxicol; 1987 Dec; 61(2):145-9. PubMed ID: 2830866
[TBL] [Abstract][Full Text] [Related]
2. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
Dencker L; Hassoun E; d'Argy R; Alm G
Mol Pharmacol; 1985 Jan; 27(1):133-40. PubMed ID: 3965925
[TBL] [Abstract][Full Text] [Related]
3. The role of receptors in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity.
Dencker L
Arch Toxicol Suppl; 1985; 8():43-60. PubMed ID: 3006634
[TBL] [Abstract][Full Text] [Related]
4. TCDD embryotoxicity in the mouse may be enhanced by beta-naphthoflavone, another ligand of the Ah-receptor.
Hassoun EM; Dencker L
Toxicol Lett; 1982 Jul; 12(2-3):191-8. PubMed ID: 6287677
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Lai ZW; Hundeiker C; Gleichmann E; Esser C
Mol Pharmacol; 1997 Jul; 52(1):30-7. PubMed ID: 9224809
[TBL] [Abstract][Full Text] [Related]
6. Effects of TCDD and its congeners 3,3',4,4'-tetrachloroazoxybenzene and 3,3',4,4'-tetrachlorobiphenyl on lymphoid development in the thymus of avian embryos.
Nikolaidis E; Brunström B; Dencker L
Pharmacol Toxicol; 1988 Nov; 63(5):333-6. PubMed ID: 3148913
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunosuppressive chemicals on lymphoid development in foetal thymus organ cultures.
d'Argy R; Bergman J; Dencker L
Pharmacol Toxicol; 1989 Jan; 64(1):33-8. PubMed ID: 2755908
[TBL] [Abstract][Full Text] [Related]
8. Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin: increased incidence of cleft palate in mice.
Birnbaum LS; Weber H; Harris MW; Lamb JC; McKinney JD
Toxicol Appl Pharmacol; 1985 Feb; 77(2):292-302. PubMed ID: 3919463
[TBL] [Abstract][Full Text] [Related]
9. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium.
Greenlee WF; Dold KM; Irons RD; Osborne R
Toxicol Appl Pharmacol; 1985 Jun; 79(1):112-20. PubMed ID: 2996175
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of 2,3,7,8,-tetrachlorodibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in mice.
Birnbaum LS; Harris MW; Miller CP; Pratt RM; Lamb JC
Teratology; 1986 Feb; 33(1):29-35. PubMed ID: 3738807
[TBL] [Abstract][Full Text] [Related]
11. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism.
Couture LA; Abbott BD; Birnbaum LS
Teratology; 1990 Dec; 42(6):619-27. PubMed ID: 2087682
[TBL] [Abstract][Full Text] [Related]
12. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
Harper PA; Golas CL; Okey AB
Mol Pharmacol; 1991 Nov; 40(5):818-26. PubMed ID: 1658612
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity of TCDD and the congener 3,3',4,4'-tetrachloroazoxybenzene in sensitive and nonsensitive mouse strains after reciprocal blastocyst transfer.
D'Argy R; Hassoun E; Dencker L
Toxicol Lett; 1984 May; 21(2):197-202. PubMed ID: 6719502
[TBL] [Abstract][Full Text] [Related]
14. Ah receptor: relevance of mechanistic studies to human risk assessment.
Cook JC; Gaido KW; Greenlee WF
Environ Health Perspect; 1987 Dec; 76():71-7. PubMed ID: 2834195
[TBL] [Abstract][Full Text] [Related]
15. An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus.
Cook JC; Dold KM; Greenlee WF
Toxicol Appl Pharmacol; 1987 Jun; 89(2):256-68. PubMed ID: 3037728
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
Poland A; Teitelbaum P; Glover E; Kende A
Mol Pharmacol; 1989 Jul; 36(1):121-7. PubMed ID: 2546046
[TBL] [Abstract][Full Text] [Related]
17. 2,2',4,4',5,5'-hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6J mice.
Biegel L; Harris M; Davis D; Rosengren R; Safe L; Safe S
Toxicol Appl Pharmacol; 1989 Mar; 97(3):561-71. PubMed ID: 2558429
[TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro.
Abbott BD; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1989 Aug; 100(1):119-31. PubMed ID: 2763295
[TBL] [Abstract][Full Text] [Related]
19. Rat embryonic palatal shelves respond to TCDD in organ culture.
Abbott BD; Birnbaum LS
Toxicol Appl Pharmacol; 1990 May; 103(3):441-51. PubMed ID: 2339417
[TBL] [Abstract][Full Text] [Related]
20. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
